The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2024 GOLD report newly highlights hyperinflation, ...

The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. Claus F. Vogelmeier, MD, chair of the GOLD ...

Effective treatment often requires you to take medications to better manage symptoms or stop taking medications if a doctor advises that you no longer need them. Finding the right dosages and ...

More than 50% of adults with low pulmonary function are undiagnosed and unaware that they have COPD. Alpha-1 antitrypsin deficiency (AATD) is also a rare genetic disorder that causes COPD. 4 Alpha-1 ...

Per the new guidelines, for patients with stable COPD, the main treatment goal would be to reduce symptoms and future exacerbation risk. With this in mind, the GOLD Report includes the following key ...